Globus Medical, Inc. (GMED) Misses Q3 EPS by 1c

Globus Medical, Inc. (NYSE: GMED) reported Q3 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $94.76 million versus the consensus estimate of $95.32 million.

For earnings history and earnings-related data on Globus Medical, Inc. (GMED) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• KeyBanc on National Fuel Gas (NFG): 'P&S Growth an Underappreciated Hedge to Weak Natural Gas Prices'
• Piper Sandler: 'Amazon.com (AMZN) AMZN Looks Best Positioned'